Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - AmeriPath, Inc. (NasdaqNM:PATH)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials
Recent Events
July 31Conference call: AmeriPath Earnings (Q2 2001)
July 23Price hit new 52-week high ($37.16)
Location
7289 Garden Road, Suite 200
Riviera Beach, FL 33404
Phone: (561) 845-1850
Fax: (561) 845-2498
Email: invrel@ameripath.com
Employees (last reported count): 2,325
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Healthcare Facilities
Company Websites
 ·Home Page
 ·Investor Relations
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 32%
·Over the last 6 months:
 · 11 insider sells; 242.0K shares
  (2.9% of insider shares)
·Institutional: 61% (89% of float)
(178 institutions)
·Net Inst. Buying: 1.65M shares (+9.74%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
AmeriPath, Inc. is a physician and laboratory company focused on providing anatomic pathology, cancer diagnostic, genomics and healthcare information services. Since its inception, the Company has completed the acquisition of 49 physician practices (the Practices) located in 21 states. These Practices are either directly owned by the Company, or managed by the Company through one of its subsidiaries. The Company essentially operates as a pathology group practice. The Company's 425 pathologists provide medical diagnostic services in outpatient laboratories owned, operated and managed by the Company, hospitals and outpatient ambulatory surgery centers. Of these pathologists, 419 are board certified in anatomic and clinical pathology, and 190 are also board certified in a subspecialty of anatomic pathology, including dermatopathology (study of diseases of the skin), hematopathology (study of diseases of the blood) and cytopathology (study of abnormalities of the cells).
More from Market Guide: Expanded Business Description

Financial Summary
AmeriPath, Inc. is an integrated physician group practice and laboratory management company providing anatomic pathology diagnostic services. For the six months ended 6/30/01, revenue increased 31% to $203.8 million. Net income applicable to Common increased 66% to $12.4 million. Revenues reflect higher outpatient revenues and acquisitions. Earnings also benefitted from improved gross and operating margins.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

James New, 55
Chairman, CEO
$600K
Brian Carr, 39
Pres, Director
--  
Gregory Marsh, 40
CFO, VP, Sec.
--  
Alan Levin, M.D., 49
COO
376K
Dennis Smith, Jr., M.D., 49
Exec. VP, Genomic Strategies and CMO
252K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:PATHAs of 31-Aug-2001
Price and Volume
52-Week Low
on 22-Sep-2000
$10.25 
Recent Price$33.23 
52-Week High
on 23-July-2001
$37.16 
Beta0.33 
Daily Volume (3-month avg)216.5K
Daily Volume (10-day avg)118.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change+149.6%
52-Week Change
relative to S&P500
+234.9%
Share-Related Items
Market Capitalization$840.1M
Shares Outstanding25.3M
Float17.2M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$10.34 
Earnings (ttm)$0.64 
Earnings (mrq)$0.35 
Sales (ttm)$14.72 
Cash (mrq)$0.10 
Valuation Ratios
Price/Book (mrq)3.21 
Price/Earnings (ttm)51.92 
Price/Sales (ttm)2.26 
Income Statements
Sales (ttm)$377.9M
EBITDA (ttm)$66.7M
Income available to common (ttm)$16.4M
Profitability
Profit Margin (ttm)4.3%
Operating Margin (ttm)13.0%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)3.05%
Return on Equity (ttm)6.85%
Financial Strength
Current Ratio (mrq)2.16 
Debt/Equity (mrq)0.81 
Total Cash (mrq)$2.49M
Short Interest
As of 8-Aug-2001
Shares Short1.14M
Percent of Float6.7%
Shares Short
(Prior Month)
546.0K
Short Ratio4.61 
Daily Volume248.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.